Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy
Authors
Keywords
-
Journal
MOVEMENT DISORDERS
Volume 32, Issue 2, Pages 246-255
Publisher
Wiley
Online
2016-12-25
DOI
10.1002/mds.26809
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Updated TDP-43 in Alzheimer’s disease staging scheme
- (2016) Keith A. Josephs et al. ACTA NEUROPATHOLOGICA
- Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP-C
- (2016) Shunsuke Koga et al. MOVEMENT DISORDERS
- Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease
- (2015) Sukriti Nag et al. ANNALS OF NEUROLOGY
- TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes
- (2015) Rachel H. Tan et al. BRAIN
- The TMEM106B locus and TDP-43 pathology in older persons without FTLD
- (2015) L. Yu et al. NEUROLOGY
- When DLB, PD, and PSP masquerade as MSA
- (2015) Shunsuke Koga et al. NEUROLOGY
- Incidence and extent of TDP-43 accumulation in aging human brain
- (2015) Akiko Uchino et al. Acta Neuropathologica Communications
- Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A
- (2014) Naoya Aoki et al. ACTA NEUROPATHOLOGICA
- Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD)
- (2014) Johannes Brettschneider et al. ACTA NEUROPATHOLOGICA
- Differential clinicopathologic and genetic features of late-onset amnestic dementias
- (2014) Melissa E. Murray et al. ACTA NEUROPATHOLOGICA
- TDP-43 is a key player in the clinical features associated with Alzheimer’s disease
- (2014) Keith A. Josephs et al. ACTA NEUROPATHOLOGICA
- TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia
- (2014) Marka van Blitterswijk et al. ACTA NEUROPATHOLOGICA
- No interaction between tau and TDP-43 pathologies in either frontotemporal lobar degeneration or motor neurone disease
- (2014) Andrew C. Robinson et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies
- (2013) Stacy J. Arnold et al. ACTA NEUROPATHOLOGICA
- Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD
- (2013) Naomi Kouri et al. ACTA NEUROPATHOLOGICA
- Staging TDP-43 pathology in Alzheimer’s disease
- (2013) Keith A. Josephs et al. ACTA NEUROPATHOLOGICA
- Stages of pTDP-43 pathology in amyotrophic lateral sclerosis
- (2013) Johannes Brettschneider et al. ANNALS OF NEUROLOGY
- TDP-43 Pathology, Cognitive Decline, and Dementia in Old Age
- (2013) Robert S. Wilson et al. JAMA Neurology
- An evaluation of the impact ofMAPT,SNCAandAPOEon the burden of Alzheimer's and Lewy body pathology
- (2012) Christian Wider et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- TMEM106B risk variant is implicated in the pathologic presentation of Alzheimer disease
- (2012) N. J. Rutherford et al. NEUROLOGY
- TDP-43 pathological changes in early onset familial and sporadic Alzheimer’s disease, late onset Alzheimer’s disease and Down’s Syndrome: association with age, hippocampal sclerosis and clinical phenotype
- (2011) Yvonne S. Davidson et al. ACTA NEUROPATHOLOGICA
- Hippocampal sclerosis in advanced age: clinical and pathological features
- (2011) Peter T. Nelson et al. BRAIN
- Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
- (2011) Heiko Braak et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Effect of topographical distribution of α-synuclein pathology on TDP-43 accumulation in Lewy body disease
- (2010) Osamu Yokota et al. ACTA NEUROPATHOLOGICA
- TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease
- (2010) Eileen H. Bigio et al. ACTA NEUROPATHOLOGICA
- Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy
- (2010) Osamu Yokota et al. ACTA NEUROPATHOLOGICA
- Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions
- (2010) Vivianna M Van Deerlin et al. NATURE GENETICS
- Common Variant inGRNIs a Genetic Risk Factor for Hippocampal Sclerosis in the Elderly
- (2010) Dennis W. Dickson et al. Neurodegenerative Diseases
- TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers
- (2010) N. Finch et al. NEUROLOGY
- Phosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodies
- (2009) Tetsuaki Arai et al. ACTA NEUROPATHOLOGICA
- Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity
- (2009) Y.-J. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Accumulation of phosphorylated TDP-43 in brains of patients with argyrophilic grain disease
- (2008) Hiroshige Fujishiro et al. ACTA NEUROPATHOLOGICA
- Argyrophilic grain disease
- (2008) I. Ferrer et al. BRAIN
- Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia
- (2008) Rosa Rademakers et al. HUMAN MOLECULAR GENETICS
- Concomitant TAR-DNA-Binding Protein 43 Pathology Is Present in Alzheimer Disease and Corticobasal Degeneration but Not in Other Tauopathies
- (2008) Kunihiro Uryu et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Pallidonigral TDP-43 pathology in Perry syndrome
- (2008) Christian Wider et al. PARKINSONISM & RELATED DISORDERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started